14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ARGS
Delisted

Argos Therapeutics Fund Predictions

$0.0536
+0 (+0%)
At Close: Apr 15, 2020
Currently predicting for Thu, 25 Apr 2024

ARGS Predictions History

5 years ago
JS predicted that ARGS for 2019-02-05 is going $0.0700 (-1.41%)

6 years ago
Antony.Greiss.11910 predicted that ARGS for 2018-04-19 is going $1.20 (9.09%)

Rank:

6 years ago
JS predicted that ARGS for 2018-01-18 is going $0.155 (14.99%)

6 years ago
bbullish2 predicted that ARGS for 2018-01-18 is going $0.151 (-6.39%)

6 years ago
JS predicted that ARGS for 2017-10-23 is going $0.169 (-94.95%)

6 years ago
Mahesh predicted that ARGS for 2017-10-23 is going $0.283 (-91.55%)

Rank:

6 years ago
mitch.bagdigian.10816 predicted that ARGS for 2017-10-16 is going $0.180 (-94.71%)

6 years ago
JS predicted that ARGS for 2017-10-16 is going $0.175 (-94.85%)

6 years ago
poiklp predicted that ARGS for 2017-10-16 is going $0.160 (-95.29%)

Rank:

6 years ago
Antonio.Diaz.12862 predicted that ARGS for 2017-10-12 is going $0.174 (-94.90%)

Rank:
Click to get the best stock tips daily for free!

About Argos Therapeutics

Argos Therapeutics, Inc. focuses on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases in North America. The company develops immunotherapies based on Arcelis, its proprietary technology platform. Its development stage products include AGS-003, which is under Phase III clinical trials for the treatment of metastatic renal cell carcinoma and other cancers; and AGS-004, which ... ARGS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT